𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Late Stent Recoil of the Bioabsorbable Everolimus-Eluting Coronary Stent and its Relationship With Plaque Morphology

✍ Scribed by Shuzou Tanimoto; Nico Bruining; Ron T. van Domburg; David Rotger; Petia Radeva; Jurgen M. Ligthart; Patrick W. Serruys

Book ID
119267787
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
544 KB
Volume
52
Category
Article
ISSN
1558-3597

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

First-in-human implantation of a fully b
First-in-human implantation of a fully bioabsorbable drug-eluting stent: The BVS poly-L-lactic acid everolimus-eluting coronary stent
✍ John A. Ormiston; Mark W.I. Webster; Guy Armstrong πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 119 KB πŸ‘ 2 views

## Abstract The first‐in‐human fully bioabsorbable drug‐eluting stent (BVS poly‐L‐lactic acid everolimus‐eluting coronary stent) implantation was performed at Auckland City Hospital, New Zealand as part of the ABSORB trial. There were no adverse events in‐hospital or by 1 month. A stent that suppor

Impact of Lesion Length and Vessel Size
Impact of Lesion Length and Vessel Size on Clinical Outcomes After Percutaneous Coronary Intervention With Everolimus- Versus Paclitaxel-Eluting Stents: Pooled Analysis From the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials
✍ Bimmer E. Claessen; Pieter C. Smits; Dean J. Kereiakes; Helen Parise; Martin Fah πŸ“‚ Article πŸ“… 2011 πŸ› American College of Cardiology 🌐 English βš– 503 KB